Exercise

Chronic Obstructive Pulmonary Disease, Second Edition

Volumn , Issue , 2012, Pages 243-269

  O’Donnell, Denis E ^a   Webb, Katherine A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136427672     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b13457-24     Document Type: Chapter

References (183)

1. Aaron EA, Johnson BD, Seow KC, Dempsey JA. Oxygen cost of exercise hyperpnea: implications for performance. J Appl Physiol 1992;72:1818-25.
2. Henke KG, Sharratt M, Pegelow DF, Dempsey JA. Regulation of end-expiratory lung volume during exercise. J Appl Physiol 1988;64:135-46.
3. Druz WS, Sharp JT. Activity of respiratory muscles in upright and recumbent humans. J Appl Physiol 1981;51:1522-61.
4. Lind F, Hesser CM. Breathing pattern and lung volumes during exercise. Acta Physiol Scand 1984;120:123-19.
5. Linnarson D. Dynamics of pulmonary gas-exchange at start and end of exercise. Acta Physiol Scand Suppl 1974;415:1-68.
6. Younes M, Kivinen G. Respiratory mechanics and breathing pattern during and following maximal exercise. J Appl Physiol 1984;57:1773-82.
7. Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in normal subjects. J Clin Invest 1969;48:564-73.
8. Warren JB, Jennings SJ, Clark TJH. Effect of adrenergic and vagal blockade on the normal human airway response to exercise. Clin Sci 1984;66:79-85.
9. Gledhill N, Froese A, Dempsey J. Ventilation to perfusion distribution during exercise in health. In: J Dempsey, C Reed, eds. Muscular Exercise and the Lung. University of Wisconsin Press, Madison, 1977, p 325.
10. Johnson BD, Badr MS, Dempsey JA. Impact of the aging pulmonary system on the response to exercise. In: IM Weisman, RJ Zeballos, eds. Clinics in Chest Medicine, vol 15. WB Saunders, Philadelphia, 1994, pp 229-46.
11. Johnson BD, Dempsey JA. Demand vs capacity in the aging pulmonary system. In: JO Holloszy, ed. Exercise and Sports Science Reviews. Williams and Wilkins, Baltimore, 1991, pp 171-210.
12. Johnson BD, Reddan DF, Pegelow KC, Seow KC, Dempsey JA. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am Rev Respir Dis 1991;143:960-7.
13. Johnson BD, Reddan WG, Seow KC, Dempsey JA. Mechanical constraints on exercise hyperpnea in a fit aging population. Am Rev Respir Dis 1991;143:968-77.
14. Anthonisen NR, Danson J, Robertson PC, Ross WR. Airway closure as a function of age. Respir Physiol 1969;8: 58-65.
15. Frank NR, Mead J, Ferris BG Jr. The mechanical behaviour of the lungs in healthy elderly persons. J Clin Invest 1957;36: 1680.
16. D’Errico A, Scarani P, Colosimo E, Spina M, Grigioni WF, Mancini AM. Changes in the alveolar connective tissue of the aging lung. Virch Arch A Pathol Anat 1989;415:137-44.
17. Gibson GJ, Pride NB, O’Cain C, Quagliato R. Sex and age differences in pulmonary mechanics in normal non-smoking subjects. J Appl Physiol 1976;41:20-5.
18. Rizzato G, Marazzini L. Thoracoabdominal mechanics in elderly men. J Appl Physiol 1970;28:457-60.
19. Knudson RJ, Clark DF, Kennedy TC, Knudson DE. Effect of aging alone on mechanical properties of the normal adult human lung. J Appl Physiol 1977;43:1054-62.
20. Tenney SM, Miller RM. Dead space ventilation in old age. J Appl Physiol 1956;9:321.
21. Leblanc P, Summers E, Inman MD, Jones NL, Campbell EJ, Killian KJ. Inspiratory muscles during exercise: a problem of supply and demand. J Appl Physiol 1988;64:2482-9.
22. Gandevia B, Hugh-Jones P. Terminology of measurements of ventilatory capacity. Thorax 1957;1:290-3.
23. Dillard TA, Piantadosi S, Rajagopal KR. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 1989;96:267-71.
24. Johnson BD, Weisman IM, Zeballos RJ, Beck KC. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest 1999; 116:488-503.
25. O’Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med 2001;164:770-7.
26. Pride NB, Macklem PT. Lung mechanics in disease. In: AP Fishman, ed. Handbook of Physiology, section 3, vol III, part 2: The Respiratory System. American Physiological Society, Bethesda, MD, 1986, pp 659-92.
27. Younes M. Determinants of thoracic excursions during exercise. In: BJ Whipp, K Wasserman, eds. Lung Biology in Health and Disease, vol 42: Exercise, Pulmonary Physiology and Pathophysiology. Marcel Dekker, New York, 1991, pp 1-65.
28. Vinegar A, Sinnett EE, Leith DE. Dynamic mechanisms determine functional residual capacity in mice. J Appl Physiol 1979;46:867-91.
29. O’Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of hyperinflation. Am Rev Respir Dis 1993;148:1351-7.
30. Grimby G, Bunn J, Mead J. Relative contribution of rib cage and abdomen to ventilation during exercise. J Appl Physiol 1968;24:159-66.
31. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest 1971;50:910-19.
32. Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic airway obstruction. Am Rev Respir Dis 1984;129:33-8.
33. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980;49:511-15.
34. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:55-9.
35. O’Donnell DE, Chau LKL, Bertley JC, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation:pathophysiologic mechanisms. Am J Respir Crit Care Med 1997;155:109-15.
36. O’Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-65.
37. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego BA, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. AmJ Respir Crit Care Med 2001; 163:1395-9.
38. O’Donnell DE, Webb KA. Breathlessness in patients with severe chronic airflow limitation: physiological correlates. Chest 1992;102:824-31.
39. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1637-41.
40. Tantucci C, Duguet A, Similowski T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J 1998;12:799-804.
41. Diaz O, Villafranco C, Ghezzo H, et al. Exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000;16:269-75.
42. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:1726-34.
43. Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease, J Appl Physiol 1968:25:21-7.
44. Ninane V, Yernault JC, de Troyer A. Intrinsic PEEP in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1993;148:1037-42.
45. Lougheed MD, Webb KA, O’Donnell DE. Breathlessness during induced lung hyperinflation in asthma:the role of the inspiratory threshold load. Am J Respir Crit Care Med 1995;152:911-20.
46. Rochester DF. The diaphragm in COPD:better than expected, but not good enough. N Engl J Med 1991;325:961-2.
47. Rochester DF, Braun NMT. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1970;132:42-7.
48. Killian KJ, Jones NJ. Respiratory muscles and dyspnea. Clin Chest Med 1988;9:237-48.
49. Meek PM, Schwartzstein RMS, Adams L, et al. Dyspnea mechanisms, assessment and management: a consensus statement (American Thoracic Society). Am J Respir Crit Care Med 1999:159:321-40.
50. O’Donnell DE. Exertional breathlessness in chronic respiratory disease. In: DA Mahler, ed. Lung Biology in Health and Disease, vol III: Dyspnea. Marcel Dekker, New York, 1998, pp 97-147.
51. Killian KJ, Campbell EJM. Dyspnea. In: C Roussos, PT Macklem, eds. Lung Biology in Health and Disease, vol 29, part B: The Thorax. Marcel Dekker, New York, 1985, pp 787-828.
52. Altose M, Cherniack N, Fishman AP. Respiratory sensations and dyspnea: perspectives. J Appl Physiol 1985;58:1051-4.
53. Chen Z, Eldridge FL, Wagner PG. Respiratory associated rhythmic firing of midbrain neurones in cats: relation to level of respiratory drive. J Appl Physiol 1991;437:305-25.
54. Chen Z, Eldridge FL, Wagner PG. Respiratory-associated thalamic activity is related to level of respiratory drive. Respir Physiol 1992; 90: 99-113.
55. Davenport PW, Friedman WA, Thompson FJ, Franzen O. Respiratory-related cortical potentials evoked by inspiratory occlusion in humans. J Appl Physiol 1986;60: 1843-8.
56. Gandevia SC, Macefield G. Projection of low threshold afferents from human intercostal muscles to the cerebral cortex. Respir Physiol 1989;77:203-14.
57. Homma I, Kanamara A, Sibuya M. Proprioceptive chest wall afferents and the effect on respiratory sensation. In: C Von Euler, M Katz-Salamon, eds. Respiratory Psychophysiology. Stockton Press, New York, 1988, pp 161-6.
58. Banzett RB, Lansing RW, Reid MB, Adams L, Brown R. ‘Air hunger’ arising from increased Pco2 in mechanically ventilated quadriplegics. Respir Physiol 1989;76:53-68.
59. Altose MD, Syed I, Shoos L. Effects of chest wall vibration on the intensity of dyspnea during constrained breathing. Proc Int Union Physiol Sci 1989;17:288.
60. Matthews PBC. Where does Sherrington’s ‘muscular sense’ originate: muscles, joints, corollary discharge? Ann Rev Neurosci 1982;5:189-218.
61. Roland PE, Ladegaard-Pederson HA. A quantitative analysis of sensation of tension and kinaesthesia in man. Evidence for peripherally originating muscular sense and a sense of effort. Brain 1977;100:671-92.
62. Noble MIM, Eisele JH, Trenchard D, Guz A. Effect of selective peripheral nerve blocks on respiratory sensations. In: R Porter, ed. Breathing: Hering-Breyer Symposium. Churchill, London, 1970, pp 233-46.
63. Zechman FR Jr, Wiley RL. Afferent inputs to breathing: respiratory sensation. In: AP Fishman, ed. Handbook of Physiology, section 3, vol II, part 2: The Respiratory System. American Physiology Society, Bethesda, MD, 1986, pp 449-74.
64. Banzett RB, Dempsey JA, O’Donnell DE, Wamboldt MZ. Symptom perception and respiratory sensation in asthma. AmJ Respir Crit Care Med 2000;162:1178-82.
65. Kukorelli T, Namenyi J, Adam G. Visceral afferent projection areas in the cortex representation of the carotid sinus receptor area. Acta Physiol Acad Sci 1969;36:261-3.
66. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-75.
67. Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways d isease. Br Med J 1988;297:1506-10.
68. O’Donnell DE, Sanii R, Younes M. Improvements in exercise endurance in patients with chronic airflow limitation using CPAP. Am Rev Respir Dis 1988;138:1510-14.
69. O’Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in COPD. Am J Respir Crit Care Med 1999;160:524-49.
70. Martinez FJ, Monies de Oca M, Whyte Rl, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. AmJ Respir Crit Care Med 1997;155:1984-90.
71. Laghi F, Jurban A, Topeli A, et al. Effect of lung volume reduction surgery on neuromechanical coupling of the diaphgram. Am J Respir Crit Care Med 1998;157:475-83.
72. O’Donnell DE, Bertley J, Webb KA, Conlan AA. Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in advanced chronic airflow limitation. Chest 1996;110:18-27.
73. Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990;69:178-88.
74. Barbera JA, Roca J, Ramirez J, Wagner PD, Usetti P, Rodriquez-Roisin R. Gas exchange during exercise in mild chronic obstructive pulmonary disease: correlation with lung structure. Am Rev Respir Dis 1991;144:520-5.
75. Dantzker DR, D’Alonzo GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;134:1135-9.
76. Dillard TA, Piantadosi S, Rajagopal KR. Prediction of ventilation at maximal exercise in chronic airflow obstruction. Am Rev Respir Dis 1985;132:230-5.
77. O’Donnell DE, McGuire M, Samis L, Webb KA. Effects of general exercise training on ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. AmJ Respir Crit Care Med 1998;157:1489-97.
78. Begin P, Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:905-12.
79. Borrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N EnglJ Med 1969;280:397-404.
80. Altose MD, McCauley WC, Kelsen SG, Cherniack NS. Effects of hypercapnia and inspiratory flow-resistive loading on respiratory activity in chronic airways obstruction. J Clin Invest 1977;59:500-7.
81. Light RW, Mahutte CK, Brown SE. Etiology of carbon dioxide retention at rest and during exercise in chronic airflow obstruction. Chest 1988:94:61-7.
82. DeTroyer A, Leeper JB, McKenzie D, Gandevia S. Neural drive to the diaphragm in patients with severe COPD. Am J Respir Crit Care Med 1997;155:1335-40.
83. Sorli J, Grassino A, Lorange G, Milic-Emili J. Control of breathing in patients with chronic obstructive lung disease. Clin Sci Mol Med 1978:54:296-304.
84. Moutain R, Zwillich C, Weil J. Hypoventilation in obstructive lung disease. The role of familial factors. N Engl J Med 1978;298:521-5.
85. 2 response and hypercapnia in severe obstructive pulmonary disease. Eur Respir J 1998;12:666-71.
86. Scano G, Spinelli A, Duranti R, et al. Carbon dioxide responsiveness in COPD patients with and without hypercapnia. Eur Respir J 1995:8:78-85.
87. Montes de Oca M, Celli B. Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;61:880-5.
88. O’Donnell DE, D’Arsigny C, Webb KA. Mechanisms of exerciseinduced hypercapnia in advanced COPD. Am J Respir Crit Care Med 2001; 63:A21.
89. O’Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med 1995;152: 2005-13.
90. O’Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow I imitation. Am J Respir Crit Care Med 1997;155:530-5.
91. Light RW, Muro JR, Sato Rl, Stansbury DW, Fischer CE, Brown SE. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989:139:126-33.
92. Bye PTP, Esau SA, Levy RO, et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic airflow limitation. Am Rev Respir Dis 1985;32:236-40.
93. Grassino A, Gross D, Macklem PT, Roussos C, Zagelbaum G. Inspiratory muscle fatigue as a factor limiting exercise. Bull Eur Pathophysiol Respir 1979:15:105-11.
94. Kyroussis D, Polkey Ml, Keilty SEJ, et al. Exhaustive exercise slows inspiratory muscle relaxation rate in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996:153:787-93.
95. Polkey Ml, Kyroussis D, Mills GH, et al. Inspiratory pressure support reduces slowing of inspiratory muscle relaxation rate during exhaustive treadmill walking in severe COPD. Am J Respir Crit Care Med 1996:154:1146-50.
96. Similowski T, Van S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N EnglJ Med 1991:325:917-23.
97. Orozco-Levi M, Gea J, Lloreta JL, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999:13:371-8.
98. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997:337:1799-806.
99. Mercadier JJ, Schwartz K, Schiaffino S, et al. Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol 1998:274: L527-34.
100. Smith K, Cook D, Guyatt GH, Madhoven J, Oxman AD. Respiratory muscle training in chronic airflow obstruction. Am Rev Respir Dis 1992:145:533-9.
101. Harver A, Mahler DA, Daubenspeck JA. Targeted inspiratory muscle training improves respiratory muscle function and reduces dyspnea in chronic obstructive pulmonary disease. Ann Intern Med 1989:111:117-24.
102. Kim J, Larson J, Covey M, Vitalo C, Alex C, Patel M. Inspiratory muscle training in patients with chronic obstructive pulmonary disease. Nurs Res 1993:42:356-62.
103. Lisboa C, Munoz V, Beroiza T, Leiva A, Cruz E. Inspiratory muscle training in chronic airflow limitation: comparison of two different training loads with a threshold device. Eur Respir J 1994:7:1266-74.
104. O’Donnell DE, D’Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:892-8.
105. Webb KA, D’Arsigny C, O’Donnell DE. Exercise response to added oxygen in patients with COPD and variable gas exchange abnormalities. Am J Respir Crit Care Med 2001;163:A169.
106. O’Donnell DE, D’Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002:166:663-8.
107. Kyroussis D, Polkey Ml, Hamnegard CH, Mills GH, Green M, Moxham J. Respiratory muscle activity in patients with COPD walking to exhaustion with and without pressure support. Eur Respir J 2000:15:649-55.
108. Mador MJ, Kufel TJ, Pineda LA, Sharma GK. Diaphragmatic fatigue and high intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000:161:118-23.
109. Hyatt RE. Expiratory flow limitation. J Appl Physiol 1983:55:1-8.
110. Roussos C, Macklem PT. The respiratory muscles. N Engl J Med 1982:307:786-97.
111. Leaver DG, Pride NB. Flow volume curves and expiratory pressures during exercise in patients with chronic airflow obstruction. Scand J Respir Dis 1971:42(suppl):23-7.
112. O’Donnell DE, Sanii R, Anthonisen NR, Younes M. Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1987:135:912-18.
113. O’Donnell DE, Sanii R, Anthonisen NR, Younes M. Expiratory resistive loading in patients with severe chronic airflow limitation: an evaluation of ventilatory mechanics and compensatory responses. Am Rev Respir Dis 1987:136: 102-7.
114. Kayser B, Sliwinski P, Yan S, Tobias M, Macklem PT. Respiratory effort sensation during exercise with induced expiratory flow limitation in healthy humans. J Appl Physiol 1997:83:936-47.
115. Aliverti A, Andelli I, Kayser B, et al. Pathophysiology of expiratory flow limitation (EFL): blood volume shifts. Eur Respir J 2000;16(suppl 31):190S.
116. O’Donnell DE, Sanii R, Giesbrecht G, Younes M. The effect of continuous positive airway pressure on respiratory sensation in patients with COPD during submaximal exercise. Am Rev Respir Dis 1988;138:1185-91.
117. Gosker HR, Wouters EF, Van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-47.
118. Casaburi R. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2001;33(suppl 7):S662-70.
119. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.
120. Hamilton AL, Killian KJ, Summers E, Jones NL. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996;110:1255-63.
121. O’Donnell DE, Webb KA. Exercise reconditioning in patients with chronic airflow limitation. In: TorgJS, Shepherd RJ, eds. Current Therapy in Sports Medicine, 3rd edn. Mosby Year Book, St Louis, MO, 1995, pp 678-84.
122. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
123. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease: the National Institutes of Health intermittent positive pressure breathing trial. Am Rev Respir Dis 1989;139:1435-8.
124. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
125. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exere 1998;30:1467-74.
126. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:374-7.
127. Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopul Rehab 1998;18:432-7.
128. Casaburi R. Deconditioning. In: AP Fishman, ed. Lung Biology in Health and Disease Series: Pulmonary Rehabilitation. Marcel Dekker, New York, 1996, pp 213-30.
129. Casaburi R. Exercise training in chronic obstructive lung disease. In: R Casaburi, TL Petty, eds. Principles and Practice of Pulmonary Rehabilitation. WB Saunders, Philadelphia, 1993, pp 204-24.
130. Cooper CB. Determining the role of exercise in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1995;27:147-57.
131. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RSY, Cooper CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:1541-51.
132. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87.
133. Green HR. Myofibrillar composition and mechanical function in mammalian skeletal muscle. In: Shepard RJ, ed. Sports Science Reviews. Human Kinetic Publishers, Champaign, IL, 1992, pp 43-64.
134. Semple PD, Bestall GH, Watson WS, Hume R. Hypothalamicpituitary dysfunction in respiratory hypoxia. Thorax 1981;36:605-9.
135. Semple PD, Bestall GH, Watson WS, Hume R. Serum testosterone depression associated with hypoxia in respiratory failure. Clin Sci 1989;58:105-6.
136. Semple PD, Watson WS, Bestall GH, Bethel MIF, Grant JK, Hume R. Diet, absorption, and hormone studies in relation to body weight in obstructive airways disease. Thorax 1979;34:783-8.
137. Takabatake N, Nakamura H, Mingmihaba O, et al. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease. Am J Respir Crit Car Med 2001; 163:1314-19.
138. Heunks KMA, Vina J, Van Herwaarden CLA, Folgering MTM, Gimeno A, Dekhuizen PNR. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 1999;277:R1697-704.
139. 2 therapy. J Appl Physiol 1996;81:2198-202.
140. Casaburi R, Patessio A, Loli F, Zanaboni S, Donner CF, Wasserman K. Reduction in exercise lactic acidosis and ventilation as a result of exercise training in obstructive lung disease. Am Rev Respir Dis 1991;143:9-18.
141. Maltais F, Leblanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
142. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
143. Kochakian CD, Stettner CE. Effect of testosterone propionate and grown hormone on weight and composition of body and organs of the mouse. Am J Physiol 1948;155: 255-65.
144. Simon M, Leblanc P, Jobin J, Desmeules M, Sullivan MJ, Maltais F. Limitation of lower limb Vo2 during cycling exercise in COPD patients. J Appl Physiol 2001;90: 1013-19.
145. Harms GA, Babcock MA, McClaren SR, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol 1997;82:1573-83.
146. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:881-5.
147. O’Donnell DE, D’Arsigny C, Raj S, Abdollah H, Webb KA. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med 1999;60:1804-11.
148. Onorati P, Rabinovich R, Mancini M, et al. Effects of proportional assist ventilation (PAV) on limb exercise in COPD. Am J Respir Crit Care Med 2000;161:A228.
149. Light RW, Mintz WM, Linden GS, Brown SE. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1984;130:391-5.
150. Mahler DA, Brent BN, Loke J, Zaret BL, Matthay RA. Right ventricular performance and central hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984;130:722-9.
151. Oswald-Mammosser M, Apprill M, Bachez P, Ehrhart M, Weitzenblum E. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 1991;58:304-10.
152. Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988;43:183-9.
153. Agusti AGN, Barbera JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990;97:268-75.
154. Matthay RA, Berger HJ, Davies RA, et al Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment. Ann Int Med 1980;93:234-9.
155. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998;113:576-83.
156. Morrison DA, Adock K, Collins CM, Goldman S, Caldwell JH, Schwartz Ml. Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987;9:1219-29.
157. Dimopoulou I, Tsintzas OK, Daganou M, Cokkinos DV, Tzelepis GE. Contribution of lung function to exercise capacity in patients with chronic heart failure. Respiration 1999;66:144-9.
158. Koskolou MD, Calbet JA, Radegran G, Roach RC. Hypoxia and the cardiovascular response to dynamic knee-extensor exercise. Am J Physiol 1997;272:H2655-63.
159. Montes de Oca M, Rassulo J, Celli BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996;154:1284-9.
160. Oelberg DA, Kacmarek RM, Pappagianopoulos PP, Grims LC, Systrom DM. Ventilatory and cardiovascular responses to inspired He-02 during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158: 1876-82.
161. Spence DPS, Hay JG, Pearson MG, Calverley PMA. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive lung disease. Effect of oxitropium bromide. Thorax 1993;48:1145-50.
162. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992;5:659-64.
163. Mahler DA, Mathay RA, Synder PE, Wells CK, Loke J. Sustained release theophylline reduces dyspnea in nonreversible obstructive airways disease. Am Rev Respir Dis 1985;131:22-5.
164. Papiris S, Galavotti V, Sturani C. Effects of beta agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Respiration 1986;49:101-8.
165. Oga T, Nishimura K, Tsukino M, Hajiro T, Ideda A, Izumi T. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med 2000;161:1897-901.
166. O’Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with ‘irreversible’ emphysema. Eur Respir J 2001; 18:914-20.
167. O’Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? Chest 2000;117:S42-57.
168. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-32.
169. Casaburi R. Exercise training in chronic obstructive lung disease. In: R Casaburi, TL Petty, eds. Principles and Practice of Pulmonary Rehabilitation. WB Saunders, Philadelphia, 1993, p 204.
170. Strijbos JW, Sluiter JH, Postma DS, Gimeno F, Koeter GH. Objective and subjective performance indicators in COPD. Eur Respir J 1989;2:666-9.
171. Reardon J, Awad E, Normandin E, Vale F, Clark B, Zu Wallack RL. The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. Chest 1994;105: 1046-52.
172. Cockroft AE, Saunders MJ, Berry G. Randomized controlled trial of rehabilitation in chronic respiratory disability. Thorax 1981;36:200-3.
173. Goldstein RS, Gork EH, Stubbing D, Avendano MA, Guyatt GH. Randomized controlled trials of respiratory rehabilitation. Lancet 1994; 344:1394-7.
174. Cambach W, Wagenaar RC, Koelman TW, van Keimpema ARJT, Kemper HCG. The long-term effects of pulmonary rehabilitation in patients with asthma and chronic obstructive pulmonary disease: a research synthesis. Arch Phys Med Rehabi1 1999;80:103-11.
175. Belman MJ, Brooks LR, Ross DJ, Mohsenifar Z. Variability of breathlessness measurement in patients with chronic obstructive pulmonary disease. Chest 1991; 99:566-71.
176. Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci 1988;74:531-7.
177. Lane R, Cockcroft A, Adams L, Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci 1987;72:693-8.
178. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in ‘pink puffers’. Lancet 1981;1:907-9.
179. Stein DA, Bradley BL, Miller W. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 1982;81:6-10.
180. Libby DM, Briscoe WA, King TKC. Relief of hypoxia-related bronchoconstriction by breathing 30 percent oxygen. Am Rev Respir Dis 1981;123:171-5.
181. Dean NC, Brown JK, Himelman RB, Doherty JJ, Gold WM, Stuhlbarg MS. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 1992;148:941-5.
182. Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in non-hypoxemic COPD patients. Eur Respir J 2001; 18: 77-84.
183. O’Donnell DE. Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exer 2001;33:S647-55.